LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
It’s Official: Attorney General Approves Sale of Daughters of Charity Health System to Prime Healthcare Services
California Attorney General Kamala Harris handed down a hotly anticipated verdict on Friday.
The data breach at Anthem Inc. was broader than initially thought and could affect customers as far back as 2004, according to media reports on Thursday.
Two Los Angeles-area hospitals were among 10 fined by the California Department of Public Health today after investigations found the facilities had not complied with licensing requirements. And their actions caused, or were likely to cause, serious injury or death to patients.
Officials with Anthem Blue Cross Inc. in Thousand Oaks were still determining Thursday how many of its California members may have had personal information compromised by a huge security breach at its parent company.
The contentious fight over the fate of six Daughters of Charity hospitals, including two in Los Angeles County, has been extended by another two weeks. The deadline by which Attorney General Kamala Harris must review and approve the sale of Daughters’ medical centers to Prime Healthcare Services has been pushed to Feb. 20.
Amgen Inc. reported fourth-quarter and full-year financial results on Tuesday that topped analysts’ estimates as the company reaped the benefits of previously announced layoffs, a tax credit and strong drug sales.
Health One Pharmaceuticals Inc., a City of Industry manufacturer of dietary supplements and drugs, has been shut down as part of a consent decree reached with the Department of Justice.
Two former employees of billionaire Patrick Soon-Shiong’s health care technology company NantHealth have alleged the firm and its Culver City holding company NantWorks had engaged in a multitude of fraudulent activities.
NantWorks, billionaire Patrick Soon-Shiong’s Culver City holding company, has launched an immuno-oncology company and inked a deal with Amgen Inc. of Thousand Oaks to license an oncology antibody.
Arrowhead Research Corp. saw its stock plummet 24 percent Monday after the Food and Drug Administration placed a partial clinical hold on one of its drugs.
Vincent Mehdizadeh, founder and majority shareholder of West Hollywood’s Medbox Inc., notified investors Friday that he will replace the marijuana dispensing company’s board of directors, its chief executive and its chief financial officer.
CytRx Corp. saw its stock rise 7 percent on Thursday following more good news from clinical trials. The West L.A. biopharmaceutical firm announced positive results from a study of a potential treatment for HIV-related skin cancer. Shares rose 25 cents to close at $3.64.
A U.S. Food and Drug Administration advisory panel on Wednesday unanimously recommended the agency approve a “biosimilar” version of Amgen Inc.’s cancer drug Neupogen. The FDA panel concluded that Zarzio, a drug sold by the generic drug division of Swiss pharmaceutical giant Novartis Group, is highly similar to the Thousand Oak’s biopharmaceutical company’s Neupogen.
Los Angeles City Attorney Mike Feuer announced today that his office has filed a civil lawsuit against a man who allegedly peddled over $280,000 in pirated movies, videogames and music in downtown L.A.’s fashion district.
CytRx Corp. saw its stock rise 16 percent on Tuesday after the West L.A. biopharmaceutical firm announced positive results from a study of a potential treatment for a form of brain cancer. Shares rose 45 cents to close at $3.30.